Fidelity Fd.S.Health C.Fd.A Acc HUF/  LU1273508686  /

Fonds
NAV2024-04-18 Chg.+10.0000 Type of yield Investment Focus Investment company
6,446.0000HUF +0.16% reinvestment Equity Worldwide FIL IM (LU) 

Investment strategy

The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics. In actively managing the fund, the Investment Manager considers growth and valuation metrics, company financials, return on capital, cash flows and other measures, as well as company management, industry, economic conditions, and other factors. The Investment Manager also considers ESG characteristics when assessing investment risks and opportunities. In determining favourable ESG characteristics, the Investment Manager takes into account ESG ratings provided by Fidelity or external agencies. Through the investment management process, the Investment Manager aims to ensure that investee companies follow good governance practices. The fund assesses the ESG characteristics of at least 90% of its assets. When selecting investments, the fund"s investment universe will be reduced by at least 20% after excluding issuers based on their ESG characteristics. The fund adheres to the Fidelity Sustainable Family of Funds standards.
 

Investment goal

The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI ACWI Health Care Index (Net)
Business year start: 05-01
Last Distribution: -
Depository bank: Brown Brothers Harriman (Lux) S.C.A.
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland
Fund manager: Alex Gold
Fund volume: 1.6 bill.  EUR
Launch date: 2015-08-20
Investment focus: -

Conditions

Issue surcharge: 5.25%
Max. Administration Fee: 1.50%
Minimum investment: 2,500.00 HUF
Deposit fees: 0.35%
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: FIL IM (LU)
Address: Kärntner Straße 9, Top 8, 1010, Wien
Country: Austria
Internet: www.fidelity.at
 

Assets

Stocks
 
98.62%
Mutual Funds
 
1.36%
Others
 
0.02%

Countries

United States of America
 
63.58%
Switzerland
 
8.85%
Denmark
 
7.50%
United Kingdom
 
6.78%
Ireland
 
4.47%
France
 
4.31%
Germany
 
1.42%
Belgium
 
1.11%
Netherlands
 
0.60%
Others
 
1.38%

Branches

Healthcare services
 
39.67%
Pharma/Biotechnology
 
33.84%
Healthcare appliances
 
19.84%
Parma, wholesale
 
1.94%
Clothing
 
1.88%
grooming products
 
1.46%
Others
 
1.37%